Collaboration to Develop Tools to Help Make Informed Decisions Related to COVID-19

Anthem, Inc. introduced a suite of digital tools that provide in-depth, trusted, and aggregated information for multiple stakeholders to use in making informed, data-driven decisions during the COVID-19 pandemic, the company said.

Led by Anthem, Inc.´s new C19 Explorer and C19 Navigator, these decision support tools are also designed to assist public health officials and business leaders as they plan for re-opening and return-to-workplace. This work is part of Anthem´s best-in-class data scientists and clinicians collaborating with a global alliance of leaders, such as TM, CloudMedx,, and

Anthem will make these tools easily accessible to stakeholders through its new portal, which will contain links to the suite of COVID-related tools Anthem has introduced in the past several weeks to help consumers.

The tools include:

C19 Explorer: Intended for government officials, healthcare leaders and community leaders, C19 Explorer provides intuitive, interactive dashboards on the COVID-19 situation — both current and predictive — regarding areas such as infection rate and community risk scores.

C19 Navigator: C19 Navigator is designed for Anthem employer customers, including states and other governmental entities, for their plan populations, to provide clinical insight and predictions, as these organizations consider their next steps on how to reopen.

Sydney Care: Digital-first consumer application that delivers personalized engagement and real-time access to health information, telehealth services, and AI-driven symptom checker.

Safer Entry to Workplace (via Biometric Passport): Biometric Passport includes the ability to evaluate employees´ possible COVID-19 symptoms through daily attestations, empowering employers to use this information for strategic planning.

Anthem is a health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 108 million people, including more than 42 million within its family of health plans. For more information, visit